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Studies of hedgehog signaling in prostate development using anti-Shh antibodies, chemical inhibitors of hedgehog signaling and Shh−/−
mutant mice have yielded conflicting data regarding the requirements of hedgehog signaling for normal ductal budding and glandular
morphogenesis. We used transgenic mouse models in combination with chemical inhibitors and renal grafting to clarify the role of Hh
signaling in prostate development. These studies showed that genetic loss of Shh is accompanied by an up-regulation of Indian Hedgehog
(Ihh) and maintenance of Hh pathway activity. We found that while neither Gli1 nor Gli3 are required for normal prostate ductal budding,
the urogenital sinus (UGS) of the Gli2−/− mutant mouse displays aberrant ductal budding in utero. When grown as a subcapsular graft, the
Gli2−/− UGS exhibited prostatic differentiation but also displayed areas of focal epithelial hyperplasia. Functional redundancy between the
three Gli transcription factors appears to mitigate the effect of Gli2 LOF as evidenced by residual Hh pathway activity in the E14 Gli2−/−
UGS that could be inhibited by cyclopamine treatment. Together, these studies reveal a surprising degree of functional redundancy operating
both at the level of the ligand and at the level of transcriptional regulation that effectively mitigates phenotypes associated with Hh-signaling
perturbations.
© 2005 Elsevier Inc. All rights reserved.Keywords: Sonic Hedgehog; Indian Hedgehog; Prostate development; Gli1; Gli2; Gli3; Budding; Differentiation; UGS; Functional redundancyIntroduction
Sonic hedgehog (Shh), a homolog of the Drosophila
hedgehog gene, encodes a secreted peptide that exerts its
effects by activating gene transcription in adjacent target
cells (McMahon, 2000). Binding of Shh peptide to the
integral membrane receptor Patched (Ptc) on target cells
initiates an intracellular signal transduction cascade activat-
ing expression of Hh target genes through the Gli family of
transcription factors (Johnson and Scott, 1998; Ingham and
McMahon, 2001). The importance of Hh signaling during
development has been reported in many systems including
the lung (Litingtung et al., 1998), gastrointestinal tract
(Roberts et al., 1998), developing CNS (Echelard et al.,
1993), and developing limbs (Pagan et al., 1996). In the
developing prostate, Shh is expressed specifically in the⁎ Corresponding author. Fax: +1 608 265 8133.
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Expression is increased late in gestation and localizes to the
nascent ductal buds of the newborn prostate. Shh expression
declines gradually after birth and is maintained at a low
level in the adult prostate (Lamm et al., 2002).
Functional studies of Hh signaling in prostate develop-
ment have used antibody blockade, chemical inhibition, and
genetic loss-of-function (LOF) models (Berman et al., 2004;
Freestone et al., 2003; Lamm et al., 2002; Podlasek et al.,
1999). These studies have yielded conflicting data on the
requirement of Shh for normal prostate development.
Antibody blockade using a polyclonal antibody to Shh
blocked prostate development in a sub-capsular renal graft
model (Podlasek et al., 1999). Chemical inhibition of Hh-
signaling with cyclopamine has produced a variety of
results, including inhibition of ductal budding (Lamm et
al., 2002), altered ductal bud morphology (Berman et al.,
2004), increased ductal branching (Freestone et al., 2003)
and altered epithelial differentiation (Wang et al., 2003).
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showed that the UGS from the Shh mutant could undergo
budding morphogenesis in organ culture and, when
transplanted under the renal capsule of an adult male host
mouse, could undergo glandular morphogenesis with normal
prostate morphology (Berman et al., 2004). In these studies,
however, it is important to note that while cyclopamine
globally blocks Hh signal transduction, functional compen-
sation may occur in transgenic mice lacking a single Hh
ligand.
The transcriptional response to Hh signaling is mediated by
three closely related Gli proteins: Gli1, Gli2 and Gli3. Gli1 and
Gli2 are thought to be transcriptional activators while Gli3 acts
primarily as a transcriptional repressor and may serve to balance
and refine transcriptional activation by Gli1 and Gli2. In the
absence of Shh, Gli3 is cleaved to a truncated form that functions
as a transcriptional repressor. Hh signaling prevents cleavage of
Gli3 to the repressor form thus permitting the full length,
unprocessed Gli3 to participate in transcriptional regulation (Dai
et al., 1999). Localization studies of Ptc andGli gene expression
in the developing prostate by whole mount in situ hybridization
showed Gli1, Gli2 and Gli3 expression localized primarily to
mesenchyme surrounding the epithelial buds—consistent with
the concept that Shh is an epithelial signal which activates Gli
expression in adjacent mesenchyme (Lamm et al., 2002; Pu et
al., 2004). However, lower level expression of several Gli genes
is also present in the epithelium of the UGS (Lamm and
Bushman, 2005; Pu et al., 2004; Gao et al., 2005). Studies in
several systems suggest a functional overlap in the activities of
the Gli transcription factors—indicating potential for redun-
dancy in Gli-mediated gene activation in addition to potential
redundancy at the level of the ligand.
Our studies demonstrate that functional redundancy of Hh
signaling exists both at the level of the Hh ligand and in
downstream transcriptional activation by the Gli transcription
factors during prostate development. The consequence of this is
that neither genetic loss of Shh function nor disruption of a
single Gli gene is adequate to completely disrupt Hh signaling.
While both of these redundancies are not novel findings in the
broader sense, their establishment in the context of prostateTable 1
Gene-specific primers used for RT-PCR
Gene symbol Gene name Forward prim
GAPDH Glyceraldehyde-3-phosphate dehydrogenase AGC CTC GT
Shh Sonic hedgehog AAT GCC TT
Ihh Indian hedgehog GAG CTC AC
Ptch1 Patched homolog 1 CTC TGG AG
Hhip Hedgehog-interacting protein CCT GTC GA
Gli1 GLI-Kruppel family member GLI1 GGA AGT C
Gli2 GLI-Kruppel family member GLI2 CCT TCT CC
Pbsn Probasin GGA GGA G
Myh 11 (HCM) Myosin, heavy polypeptide 11, smooth muscle GCT CCA AG
Nkx3.1 NK-3 transcription factor, locus 1 GAA AGC A
Nes Nestin GGA CAG G
Bmi1 B lymphema Mo-MLV insertion region 1 ATG AGT CA
Krt1-14 (CK14) Keratin complex 1, acidic, gene 14 CAA GGATGdevelopment will help in sorting out previously conflicting
reports regarding the role of Hh signaling in the prostate.
Materials and methods
Tissues
Animal procedures were performed in accordance with the guidelines of the
University of Wisconsin-Madison's Animal Care and Use Committee. Gli1+/−
and Gli2+/−mice were generously provided by Alexandra Joyner and maintained
on an outbred CD-1 background. Gli3+/xt mice were obtained from Jackson
Laboratories and were maintained on a C57/C3H background. Timed pregnant
females were generated in-house by crossing heterozygous males to hetero-
zygous females. Adult male CD-1 nude mice were purchased from Charles
River Laboratories. Mice were sedated with halothane, euthanized by cervical
dislocation, and urogenital sinuses and prostates were harvested by dissection in
Dulbecco's PBS (Invitrogen). For microdissection experiments, collagenase was
added to PBS to facilitate quantitative counts of bud tips/branch points (Lamm et
al., 2001). Tissue samples were either snap frozen in liquid nitrogen and stored at
−80°C for RNA isolation or fixed and stored in 10% formalin for
immunohistochemistry.
RNA isolation and RT-PCR
Frozen tissue specimens were homogenized in lysis buffer containing
molecular grinding resin (Geno Technology Inc) and total RNA was isolated
with RNeasy columns (Qiagen) according to the manufacturer's recommenda-
tions. Isolated RNA was subjected to DNase treatment and reverse-transcribed
using standard protocols. Real-time RT-PCR was performed with gene-specific
primers (Table 1) and mRNA content was normalized to glyceraldehyde-3-
phosphate dehydrogenase (Gapdh) expression. Products were detected by
SYBR green fluorescence using an iCycler thermocycler (Bio-Rad Labora-
tories). For each experimental replicate, PCR reactions were run in duplicate and
values were then averaged.
Whole mount in situ hybridization
In situ hybridization of 4% paraformaldehyde fixed urogenital tissues was
performed according to previously described protocols with a few modifications
(Wilkinson et al., 2002; Lamm et al., 2002). Briefly, the tissue was bleached for
1 h in 6% hydrogen peroxide then treated with 50 μg/ml proteinase K for 30 min.
The tissue was re-fixed in 0.2% gluteraldehyde/4% paraformaldehyde then pre-
hybridized at 68°C on a rotator for 1 h. Hybridization was performed at 68°C
overnight. Five high stringency post hybridization washes were followed with
alkaline phosphatase-conjugated anti-digoxigenin antibody (Roche) overnight
incubation at 4°C. The 6–8 h color reaction was developed using NBTand BCIPer sequence Reverse primer sequence
C CCG TAG ACA AAAT CCG TGA GTG GAG TCA TAC TGG
G GCC ATC TCT GT GCT CGA CCC TCATAG TGT AGA GAC T
C CCC AAC TAC AA TGA CAG AGATGG CCA GTG AG
C AGATTT CCA AGG TGC CGC AGT TCT TTT GAATG
G GCT ACT TTT CG TCC ATT GTG AGT CTG GGT CA
CT ATT CAC GCC TTG A CAA CCT TCT TGC TCA CAC ATG TAA G
A ATG CCT CAG AC GGG GTC TGT GTA CCT CTT GG
AT GAG GGA GTT CA ACA GTT GTC CGT CTG CAT GA
G ATG ATG TAG GC TCT CTT CCA TCT GGG TCT CC
GC TGT CGG AAG AC ACA CGG AGA CCA AGG AGG TA
AC CAA GAG GAA CA TCT CGATCC ACC TTT TCT GG
C CAG AGG GAT GG AAG AGG TGG AGG GAA CAC CT
C TGA GGA ATG GT CCG GAG CTC AGA AAT CTC AC
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The pre-hybridization, hybridization, and post-hybridization steps were
performed at 70°C inside a humidified chamber.
Probe synthesis
A full-length (2.6 kb) cDNA mouse Shh product was generated using a DIG
RNA labeling Kit from Roche. The mShh antisense probe was transcribed from
the linearized mouse Shh plasmid (generously provided by the M. Scott Lab)
using EcoRI and T7 polymerase. The full-length riboprobe product was
hydrolyzed to produce an ideal probe length between 500 bp and 1 kb. Probe
concentration of 1 μg/ml hybridization buffer was used.
Immunohistochemistry
For double labeling experiments, mouse anti-p63 monoclonal antiserum
(1:200, Santa Cruz Biotech), mouse anti-smooth muscle actin monoclonal
antiserum (1:400, Sigma), and rabbit anti-pan-cytokeratin polyclonal antiserum
(1:100, Santa Cruz Biotech) were directly labeled with Alexa Fluor Antibody
Labeling Kits (Molecular Probes) and applied in succession to 4 μm paraffin
sections for 1–2 h at room temperature. Rabbit anti-Ki67 polyclonal antiserum
(1:300, Novacastra), goat anti-rabbit-Alexa 546 antiserum, and florescein-
conjugated mouse anti-E-cadherin antiserum (BD Biosciences) were used at RT
with incubation times ranging from 0.5 to 2 h. TUNEL staining was performed
using an In Situ Cell Death Detection Kit (Roche). Slides were mounted using
Hardset Media + DAPI (Vector), cover-slipped, and imaged with a fluorescent
microscope equipped with a digital camera and processed with SPOT QE
software (Diagnostic Instruments).
Cell-based assays
A clonal line of UGSM-2 cells was produced from immortalized cells
isolated from the urogenital sinus of an E16 INK4a−/− mouse. The isolation
procedure and characterization of UGSM-2 cells is described elsewhere (Shaw
and Bushman, in press). Cells were plated at confluency in 10% FBS and
allowed to attach overnight. The following day, media was removed and
replaced with 0.1% FBS containing 500 nM Ihh peptide (R&D Systems) or 1
nM octylated human Shh peptide (Curis)F μM cyclopamine (Toronto Research
Chemicals). A lower concentration of octylated Shh peptide was used because
that form was found to be 500 times more potent than the non-octylated form
from R&D Systems (data not shown). Cells were harvested 48 h after treatment
and RNAwas isolated as described above.
Organ culture experiments
Dissected E14 UGS tissues were placed on 0.4 μm Millicell-CM filters
(Millipore) in tissue culture plates containing serum-free DMEM/F12 media F
10 μM cyclopamine supplemented with 2% insulin–transferrin–selenium (ITS),
25 μg/ml gentamycin, 0.25 μg/ml amphotericin B, and 10−8 M 5α-
dihydrotestosterone (DHT). Media was changed every 2 days. UGS tissues
were harvested at day 7, and snap frozen in liquid nitrogen for RNA isolation.
RNA for each replicate was isolated from a single UGS tissue.
Renal grafts
Dissected E14 UGS tissues were placed under the renal capsule of CD-1
adult male nude mice as previously described in Kurita et al. (2004). After 3–5
weeks, grafts were harvested and either snap frozen in liquid nitrogen or fixed in
10% formalin for immunohistochemistry. RNA for each experimental replicate
was isolated from a single UGS graft.
Quantification of epithelial and p63 positive cells
Eight to ten high-power fields (400×) were randomly selected from
digital images of tissue samples. P63+ cells were determined using IHC as
described above and epithelial cells were determined by nuclear
morphology.Androgen supplementation
Gli2+/− females were mated with Gli2+/−males and supplemented with 2 mg
testosterone pellets at E12. Pellets were constructed using silicone tubing (Helix
Medical), wood sticks (Midwest Products Co), silicone adhesive, and
testosterone (Sigma) and were sterilized in 70% EtOH before implantation as
previously described in De Vries et al. (1994). Serum testosterone levels were
verified using an enzyme immunoassay test kit (Biocheck Inc.).
Results
Ihh maintains Hh signaling in the Shh−/− prostate
In apparent conflict with our previous observations of the role
of Shh signaling in prostate development, the Shh−/− UGS was
found to exhibit budding morphogenesis in organ culture and
to undergo glandular morphogenesis when transplanted under
the renal capsule of an adult male host mouse. We performed
a 7-day in vitro UGS organ culture of E14 WT, Shh+/− and
Shh−/− tissues to examine gene expression during this period
of ductal budding. Real time RT-PCR for Hh target genes
Gli1, Ptc1 and Hip1 showed similar levels of expression in
WT and Shh+/− mutants (not shown) and significantly
diminished expression of Gli1 and Hip1 in the Shh−/−
UGS (Figs. 1A–C). Even so, considerable Hh target gene
expression remained. The addition of 10 μM cyclopamine, a
specific Hh signaling inhibitor, to the organ culture media
demonstrated that this maintained expression was due to
residual Hh pathway activation—an observation that led us to
examine the possibility that other Hh ligands could
compensate for the loss of Shh. We examined Ihh and Dhh
expression in the Shh−/− UGS and found that Ihh expression
was significantly up-regulated as compared to WT controls
(Fig. 1D). Expression of Dhh was not changed (data not
shown). A time course of Ihh expression in WT UGS tissues
revealed that Ihh was expressed at low levels in early prostate
development (Fig. 1E). Unlike Shh expression, which is
down-regulated after birth, Ihh expression persists at compar-
able levels in all three lobes of the adult prostate (data not
shown). Ihh also exhibited a different pattern of mRNA
localization. Whereas Shh expression localized to the nascent
buds of the developing prostate ducts at P1, Ihh expression
appeared to be uniformly distributed through the epithelium
and did not localize to sites of budding (Fig. 1F). To confirm
that Ihh was capable of inducing Gli1 and Ptc1 expression
comparable to Shh, we assayed the effect of exogenous Ihh
and Shh peptide on an immortalized E16 UGS mesenchymal
cell line (Shaw and Bushman, in press) and showed that both
were able to induce robust expression of Gli1 and Ptc1 and
that the induction could be blocked by cyclopamine (Figs.
1G–H). Since Shh expression during normal prostate devel-
opment localized to sites of ductal budding, we wanted to
determine if Ihh expression in the E14 Shh−/− UGS mimicked
the canonical localization of Shh expression. Unfortunately,
the embryonic mortality of the Shh−/− fetus prior to the onset
of ductal budding precluded the study of the localization of
Ihh expression in Shh−/− UGS tissues during development in
situ. Further, we found that tissues cultured on a flat filter for
Fig. 1. Ihh maintains Hh signaling in Shh−/− UGS tissues cultured in vitro. (A–C) E14 WT and Shh−/− tissues were cultured in vitro for 7 days and analyzed for
expression of Hh pathway genes. Hh target gene expression is moderately diminished in Shh−/− UGS tissues but significant pathway activity persists that is blocked by
cyclopamine. (D) Ihh mRNA levels are elevated in Shh−/− tissues. (E) Timecourse of Ihh expression during early UGS development and (F) whole-mount in situ
hybridization comparing expression patterns of Shh and Ihh at P1 in the WT UGS. (G–H) Ihh peptide activation of Hh target gene expression in an immortalized
mesenchymal embryonic cell line (UGSM-2) is blocked by cyclopamine. *P = 0.05. Data bars represent the mean (n≥ 3) ± S.E.M. #Values were too low to be seen on
this graph.
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Ihh expression by whole mount in situ hybridization (data not
shown). We were therefore unable to determine whether the
up-regulation of Ihh expression and maintenance of Ptc1 and
Gli1 expression in the Shh−/− involves a recapitulation of the
normal pattern of Hh ligand expression and target gene
induction.Recent studies have demonstrated that in vitro organ culture
cannot recapitulate prostate differentiation in vivo and that
subcapsular grafting more closely approximates this process
(Doles et al., 2005). To exclude the possibility that up-regulation
of Ihh in the Shh−/− UGSwas a peculiarity of in vitro culture, we
examined gene expression in subcapsular grafts. E14 UGS
tissues were isolated from E14WT, Shh+/−, and Shh−/−mice and
17J. Doles et al. / Developmental Biology 295 (2006) 13–25grafted under the renal capsule of adult male nude host mice.
Grafted tissues were harvested 3 weeks later and analyzed for
glandular morphogenesis and gene expression with real-time
RT-PCR. Consistent with previous findings (Berman et al., 2004;
Freestone et al., 2003), we observed that Shh−/− UGS grafts
underwent glandular morphogenesis with a histological appear-
ance characteristic of prostatic differentiation. Gene expression
analysis showed that Ptc1 and Gli1 were expressed at
comparable levels in WT, Shh+/− (not shown) and Shh−/− grafts
(Fig. 2A). Ihh expressionwas dramatically higher in Shh−/−UGS
grafts compared toWTcontrols (Fig. 2B), whileDhh expressionFig. 2. Shh is not required for prostatic differentiation. E14 WT and Shh−/− UGS
harvested after 3 weeks growth in vivo. (A–D) Expression of Hh target genes Ptc1
Expression of Ihh, however, was significantly increased in the Shh−/− (P b 0.05). The
(Myh11) or Nkx3.1 expression. There was also no difference in expression of progen
were indistinguishable by routine histology (not shown) and by immunostaining for p
TUNEL staining showed no significant apoptosis in either group. Inset in panel G is a
the mean (n ≥ 4) ± S.E.M.was unchanged (not shown). To examine whether the fidelity of
prostate differentiation was maintained in the Shh−/−, we
examined expression of progenitor cell markers and markers of
terminal differentiation. We found that Nestin expression was
maintained at the same level in WT and Shh−/− grafts.
Cytokeratin 14 (Krt1-14) expression was increased in the
Shh−/− grafts but not significantly (Fig. 2C). WT and Shh−/−
grafts expressed the following markers of prostatic differentia-
tion—Nkx3.1, an early genitourinary marker gene that increases
in expression as the tissue matures, Probasin, an androgen-
dependent prostate-specific protein expressed by terminallytissues were grafted under the renal capsule of an adult male nude mouse and
, Gli1 and Hip1 was not significantly different between WT and Shh−/− grafts.
re was no significant difference in Probasin, smooth muscle heavy chain myosin
itor cell marker Nestin or in expression of Krt1-14. (E–J) Shh−/− and WT grafts
63 and Ki67. Scale bar = 25 μMColored arrow indicates positive Ki67 staining.
DNase treated section of intestine used as a positive control. Data bars represent
Table 2
Comparison of ductal architecture between wildtype and viable Gli mutant
mouse prostate












CG 4.0 4.3 55.0 80.7 147.3 169.3
VP 6.0 6.0 69.7 69.3 149.3 13.97
DLP 16.7 18.5 77.7 75.0 168.7 170.5












CG 4.7 5.5 62.3 54.3 114.3 100.8
VO 8.0 6.0 61.0 57.3 110.3 105.8
DLP 18.3 18.7 82.0 80.0 165.0 174.3
CG = Coagulating Gland. VP = Ventral Prostate. DLP = Dorso-lateral prostate.
Values represent the mean of 3 independent determinations.
18 J. Doles et al. / Developmental Biology 295 (2006) 13–25differentiated prostate luminal cells, and heavy chain myosin
(Myh11), a late-stage marker of smooth muscle—at similar
levels (Fig. 2D). Immunohistochemical staining for p63, smooth
muscle actin (SMA), Ki67 and TUNEL showed no obvious
differences between WT and Shh−/− grafts (Figs. 2E–J). Taken
together these studies confirm that prostatic differentiation
occurs in the absence of Shh and further show that Ihh expression
is up-regulated in Shh−/− UGS and acts to maintain Hh signaling
activity and Hh target gene activation.
Gli2 is required for normal ductal budding
Functional redundancy between Ihh and Shh in the develop-
ing prostate precludes any conclusion about the requirement forFig. 3. Shh and Gli mutant tissues bud when cultured in vitro. (A) Size comparison
tissues. (B) E14 WT, Gli2−/−, and Gli3xt/xt UGS tissues were cultured in vitro in se
essentially indistinguishable. Scale bars = 0.5 mm.Hh signaling in prostate development based on the phenotype of
the Shh−/− mouse. Since the Gli transcription factors are
common downstream effectors of Shh and Ihh, we system-
atically examined the impact of individual Gli gene knockout
mutants on prostate development to circumvent the effect of
functional compensation of Shh by Ihh. We began our study of
Gli gene function in prostate development by performing
quantitative micro-dissections of the prostate ductal-tree in the
viable adult mutants. Adult Gli2+/− and Gli3+/xt heterozygous
mutants exhibited comparable indices of ductal branching as
their WT controls (Table 2) as well as normal ductal histology
(data not shown). Gli1−/− mice have previously been reported to
be viable and without a detectable phenotype (Park et al., 2000).
Indeed, adult Gli1−/− mice displayed normal indices of ductal
branching and normal ductal histology (data not shown). We
then focused our studies on the effect of homozygous (lethal)
mutations in Gli2 and Gli3 on prostate development.
When compared at E14, the Gli1−/− and Gli3xt/xt UGS tissues
were similar in size to WT littermates. The Gli2−/− UGS was
somewhat smaller than the WT but larger than the Shh−/− (Fig.
3A). During in vitro organ culture, E14WT, Shh−/−, Gli2−/− and
Gli3xt/xt UGS tissues all exhibited comparable budding
morphogenesis (Fig. 3B). Since Shh localizes to the nascent
buds of the prostate, it is a useful marker of ductal budding and
has been used previously in a similar way to identify emerging
buds in other systems where Hh-signaling has been perturbed
(McKinnell et al., 2004, Panman et al., 2005). Further, forced
expression of Shh using a retrovirus has been shown to be
sufficient to induce feather bud formation in normally
featherless regions (Morgan et al., 1998). Thus, P1 WT,
Gli2−/− and Gli3xt/xt UGS tissues were examined by Shh
whole mount in situ hybridization. The P1 WT and Gli3xt/xt
UGS tissues showed a similar pattern of ductal budding;
although the intensity of Shh expression appeared consistentlyphotomicrograph showing relative sizes of E14 WT, Shh−/−, and Gli2−/− UGS
rum free media + DHT for 7 days. Budding in the WT and mutant tissues was
19J. Doles et al. / Developmental Biology 295 (2006) 13–25reduced in the Gli3 mutant. Even so, histologic examinations of
the P1 UGS revealed a comparable number of well-formed buds
in the WT and Gli3 mutant that were characterized by an
ordered ring of epithelial cells. In contrast, the P1 Gli2−/−
exhibited a perturbed budding pattern featuring an overall
reduction in bud number and clearly distorted pattern of buds
(Fig. 4D). This aberrant budding pattern was consistently
associated with a persistence of Shh expression in the dorsal
region that was akin to the patterns of expression seen in the WT
at E18 (not shown). Upon histological examination, the P1
Gli2−/− UGS exhibited only a few malformed buds, which
displayed an irregular spacing of the outer ring of epithelial
cells. Double immunofluorescence for high molecular weight
cytokeratin and the basal cell marker p63 showed that the
epithelial cells were abnormally crowded and displayed a loss of
normal polarity and organization (Fig. 4F). To rule out the
possibility that Gli2−/− fetus could be functionally hypogonadal
because of the critical role of Hh signaling in pituitary
development and gonadogenesis (Roessler et al., 2003;Fig. 4. Gli2−/−UGS tissues display abnormal budding patterns and improper bud form
reproducible budding pattern as evidenced by Shh whole mount in situ hybridiza
morphology characterized by an ordered ring of p63+ cells surrounding a lumen
characterized by a distorted budding pattern, a markedly reduced number of buds ev
crowded basal layer of p63+ cells. (G–I) The budding pattern is preserved in the Gli3x
situ hybridization is reduced. The buds appear normal in number and histologic a
unperturbed. Arrows indicate prostatic buds. Scale bar in panel A = 0.5 mm, panelKarlstrom et al., 1999; Persengiev et al., 1997), we examined
the effect of testosterone supplementation of the pregnant dams
beginning at E12. Examination of the E18.5 WT and Gli2−/−
female pups showed that testosterone supplementation induced
the canonical pattern of ductal budding in the WT females;
however, androgen supplementation did not rescue normal
budding in Gli2−/− females (Figs. 5A–B) or Gli2−/− males (data
not shown). This observation indicates that abnormal budding
in the Gli2−/− tissues was not a result of hypogonadism, but was
a morphogenetic phenotype of Gli2 LOF. Ki67 and TUNEL
staining showed no difference in epithelial proliferation or
apoptosis in the WT and Gli2−/− tissues (Figs. 5C–F). To
determine whether Shh expression was expressed in buds that
formed in the Gli2−/−, we performed in situ hybridization for Shh
on sections of the E18.5 WT and Gli2−/− UGS. The WT UGS
showed Shh expression localized to the basal layer of epithelial
cells in the nascent buds. In the Gli2−/−, Shh expression was
clearly localized to the epithelium but was more diffuse within
the bud and did not localize to the basal layer. The discrepancyation. (A–C) Normal ductal budding in theWT UGS is characterized by a highly
tion of the P1 UGS, numerous and ordered buds in H&E sections, and bud
filled with CK+ cells. (D–F) Abnormal budding in the Gli2−/− mutant was
ident in H&E sections, and a disordered bud structure featuring an irregular and
t/xt UGS although the intensity of staining for Shh expression on whole mount in
ppearance on H&E staining and the pattern of p63+ cells in the buds appears
B = 100 μM, and panel C = 10 μM. n ≥ 3 for each genotype.
Fig. 5. Abnormal budding in the Gli2−/− UGS is not a function of
hypogonadism. Mutant dams produced by a (Gli2+/− × Gli2+/−) cross were
supplemented with testosterone at E12 and embryos were harvested at E18.5.
Whole-mount in situ hybridization for Shh demonstrated that androgen
treatment induced the canonical pattern of prostate budding in the WT female
(A) which was absent from untreated control females (not shown). The
abnormal pattern of ductal budding in the Gli2−/− female was not rescued by
androgen treatment (B). Scale bar = 100 μM. Similarly, androgen supplement
did not affect the abnormal pattern of budding in the Gli2−/− male (not
shown). (C–F) Assays in unsupplemented males revealed no difference in
proliferation or cell death in or around developing buds in these tissues. Scale
bar = 10 μM. (G–H) Sectional in situ hybridization for Shh expression shows
crisp localization of Shh mRNA to the basal regions of the epithelial buds in
WT specimens which contrasts with the more diffuse staining observed in the
ductal buds of the Gli2−/− mutant. Scale bar = 10 μM. White arrows indicate
prostatic buds; colored arrows indicate positive Ki67/TUNEL staining.
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budding in serum free organ culture suggests that budding in
organ culture may not accurately replicate or assess the
canonical process of prostate ductal morphogenesis. Alterna-
tively, it is possible that the supplemented factors in serum freeorgan culture compensate for or bypass the requirement for Gli2
in early prostate development.
To determine whether Gli2 is required for normal prostatic
epithelial differentiation, we examined the fate of the E14
Gli2−/− UGS grafted under the renal capsule (Fig. 6). Gene
expression analysis in the grafted tissues showed that Nkx3.1,
Probasin andMyh11 were expressed at similar levels in WTand
Gli2−/− grafts. Expression ofKrt1-14was the same in the Gli2−/−
and WT grafts, but expression of progenitor cell markers Nestin
and Bmi-1 were significantly diminished. Histologic examina-
tion of the Gli2−/− grafts after 5 weeks growth in vivo revealed
aberrant histology characterized by epithelial hyperplasia. Some
areas of the Gli2−/− grafts exhibited a normal ductal histology
characterized by a single layer of epithelial cells along the
basement membrane. However, all of the grafts displayed areas
of hyperplasia with focal tufting and a generalized increase in the
thickness of the epithelial cell layer (Fig. 6). Immunostaining for
E-cadherin was performed which highlights this multilayer
epithelial hyperplasia. Immunostaining for p63 revealed pockets
of intense staining (Fig. 6I) and an overall increase in the number
of p63+ cells per high power field (HPF). Despite the appearance
of hyperplasia, we observed no obvious difference in Ki67 or
TUNEL staining in the 5 week grafts.
Functional redundancy in Gli mediated transcriptional
activation
Gli1 and Gli2 are considered to be the primary transcriptional
activators in the Hh signaling pathway. We recently reported a
quantitative study of individual and cooperative roles of Gli1
and Gli2 in Hh-induced transcriptional activation using mouse
embryonic fibroblasts derived from Gli mutant mice (Lipinski et
al., submitted). These studies showed normal gene activation in
Gli1−/−MEFs, a significant impairment of target gene activation
associated with Gli2 LOF and profound impairment of
transcriptional activation in the Gli1−/−Gli2−/− compound
mutant cells. These studies demonstrated that Shh stimulated
target gene expression is preserved at near normal levels in the
complete absence of Gli1 function and are diminished, but not
abrogated, in the absence of Gli2 function. To determine whether
functional redundancy mitigates the effect of Gli2 inactivation
on prostate development, we performed real-time RT-PCR for
Shh, Gli1, Gli2, Ptc1 and Hip1 in the WT and Gli2 mutant UGS
(Fig. 7). After culture for 7 days, the Gli2−/− UGS showed the
expected absence of Gli2 expression (not shown). Although only
Hip1 expression was significantly diminished, Gli1 and Ptc1
mRNA levels were also reduced despite adequate levels of Shh
expression, consistent with the effect of Gli2 LOF on Hh-
induced gene activation. However, target gene expression was
further and significantly reduced when 10 μm cyclopamine was
added to the culture media. This finding confirms that residual
Hh-induced target gene activation persists in the Gli2−/− UGS.
Discussion
The role of Hh signaling in prostate development and
differentiation has become a subject of intense interest since
Fig. 6. Effect of Gli2 LOF on prostatic differentiation. E14 WT and Gli2−/− UGS tissues were grafted under the renal capsules of adult male nude mice and harvested
after 5 weeks growth in vivo. (A–C) Expression of the Hh target gene Gli1 was significantly reduced. There was no significant difference in the expression of
Probasin, Myh11 or Nkx3.1. There was also no difference in expression of Krt1-14, however, expression of early progenitor cell markers Nestin and Bmi-1 was
significantly diminished.N = 4 for each genotype. (D–I) Histologic examination revealed areas of epithelial hyperplasia in the Gli2−/− grafts that were characterized by
a multilayered epithelium and focal areas of p63+ epithelial hyperplasia. ( J–M)We did not observe any difference in Ki67 and TUNEL staining ( J–M) as compared to
WTcontrols. Inset in panel G is a DNase treated section of intestine used as a positive control. Quantitative analysis did not reveal a generalized increase in the number
of epithelial cells/HPF (not shown) but did show a significant increase in the number of p63+ cells/HPF (N). Scale bar in D = 50 μM, all others = 10 μM. **Indicate
ductal lumen.
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in prostate tumor growth and progression (Fan et al., 2004;
Karhadkar et al., 2004; Sanchez et al., 2004; Sheng et al., 2004).
Data presented by several groups using a variety of methodol-ogies are in agreement that Hh signaling is critically important
for normal prostate development. However, these reports have
also illuminated areas of disparity in conclusions regarding the
specific requirements of Hh signaling for prostatic induction,
Fig. 7. Functional redundancy in Gli-mediated target gene expression. E14 WT and Gli2−/− tissues were cultured in vitro for 7 days ± cyclopamine and analyzed for
expression of Hh pathway genes. (A–C) Expression of Ptc1,Gli1 andHip1 in WTand Gli2−/− tissues was dramatically inhibited by cyclopamine. (D) Control assay of
Shh expression revealed no inhibition by cyclopamine. N = 3 for each genotype. (*) P ≤ 0.05.
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(Podlasek et al., 1999; Lamm et al., 2002; Wang et al., 2003;
Berman et al., 2004). The studies reported herein offer a new
perspective on previously published data by showing that Hh
signaling in prostate development is reinforced by functional
redundancy at both the level of the ligand as well as in target-
gene transcriptional activation. These functional redundancies
make it difficult to definitively analyze Hh signaling during
prostate development by using single-gene transgenic mutant
models.
As previously reported by others, we observed that Shh is not
required for initiation of budding morphogenesis of the UGS in
serum-free organ culture (Freestone et al., 2003; Berman et al.,
2004). It had been inferred from this that Hh signaling is not
required for prostate ductal budding in vivo. However, we
present two observations that preclude such a conclusion. The
first is that budding morphogenesis during organ culture of the
UGS in vitro is not always an accurate reflection of budding in
vivo. This is suggested by the discrepancy in budding of the
Gli2−/− UGS in vitro versus in vivo. The second is that increased
Ihh expression activates Hh-dependent target gene expression in
the Shh−/− UGS (Fig. 1). Yang et al. (1998) demonstrated that
Ihh has similar activity in inducing limb bud formation when
expressed in Shh responsive tissue. Further, compensation by
Ihh for Shh LOF has been reported previously (Zhang et al.,
2001; Kraus et al., 2001, Gallego et al., 2002). Althoughwewere
unable to determine the correspondence between Ihh expression
and budding, these results suggest that Shh LOF is functionally
compensated by Ihh. Although further experimentation would
be necessary to determine the underlying mechanism behind this
compensation, these experiments do demonstrate that Ihh is
sufficient to maintain Hh pathway activity. Our finding that Ptc1
and Gli1 expression are maintained in the Shh−/− UGS does notagree with previously reported results that Ptc1 expression could
not be detected in cultured Shh−/− tissues by in situ hybridization
(Berman et al., 2004), but the discrepancy may be explained by
the greater sensitivity of quantitative RT-PCR as a measure of
gene expression.
Our findings prompt a re-examination of previous studies
looking at blockade of Hh signaling by polyclonal
antibodies and chemical inhibitors. When the polyclonal
anti-Shh antibody Ab80 was found to inhibit glandular
morphogenesis in subcapsular grafts of the E15 UGS, RT-
PCR assay showed a significant decrease in Ptc1 expression
(Podlasek et al., 1999). This contrasts with the effect of
genetic inactivation of Shh alone and suggests that the
polyclonal antibody blocked both Shh and Ihh ligand. The
effect of chemical inhibitors of Hh signaling on prostate
development has only been assayed in vitro. Our compar-
ison of ductal budding in the Gli2−/− UGS shows that in
vitro culture does not always accurately reflect the canonical
process of ductal budding in vivo. Similarly, our recent
studies have shown that prostatic differentiation does not
occur in organ culture of the prenatal UGS (Doles et al.,
2005). Therefore, the finding that in vitro budding occurs
even in the presence of cyclopamine does not definitively
prove that Hh signaling is not required for either ductal
budding or prostatic development but does prompt an in
vivo investigation into the matter.
Stymied in our efforts to elucidate the requirement for Hh
signaling in prostate development by the redundancy in Hh
ligand, we systematically examined the impact of individual
Gli gene mutations on prostate development. Previous
studies have found strikingly different requirements for the
three Gli transcription factors on Hh-dependent develop-
mental processes (reviewed in Ingham and McMahon,
23J. Doles et al. / Developmental Biology 295 (2006) 13–252001). The Gli3xt/xt mutant is non-viable and displays
grossly distorted development of the limbs and several other
organs consistent with overactive Hh signaling (Schimmang
et al., 1992). Gli1 has been stated to be the major
transcriptional activator of Hh target genes but both Gli1
and Gli2 contribute to transcriptional activation by Hh
ligand (Ruiz i Altaba, 1999). In fact, the Gli1−/− transgenic
mutant is phenotypically normal (Park et al., 2000) while
the Gli2−/− mutant is non-viable and displays variable
phenotypes associated with Shh LOF, presumably due to
functional overlap between the 3 Gli genes that mediate the
Hh signal. (Bai and Joyner, 2001). Interestingly, while
Gli1−/− and Gli2+/− mutants are phenotypically normal, the
Gli1−/−Gli2+/− double mutant is non-viable (Park et al.,
2000). While this observation is explained by functional
redundancy and complementation between Gli1 and Gli2
(Bai and Joyner, 2001), the reason for the discrepancy in the
phenotypic effects of Gli1 and Gli2 LOF is not precisely
understood.
We observed diminished activation of the Hh target genes
Glil, Ptc1 and Hip1 in the Gli2−/− UGS despite adequate
levels of Shh expression, consistent with the anticipated effect
of Gli2 LOF on Hh-induced gene activation. However, this
effect was only a partial disruption of Hh signaling,
presumably due to the compensatory action of other Gli
transcription factors, as shown by the observation that
residual pathway activity could be effectively blocked by
the addition of cyclopamine. Despite this redundancy, the
number, pattern and morphology of buds in the Gli2−/− was
significantly perturbed. Since normal budding could not be
rescued by testosterone supplementation of the dams, this
observation indicates that abnormal budding in the Gli2
mutants is not a result of hypogonadism and suggests that the
perturbed budding phenotype results from Gli2 LOF. Gli2 has
not been reported to participate in any activities independent
of Hh signaling and the phenotype of the Gli2 mutation in
other systems are all similar to the disturbance of Hh
signaling (Ding et al., 1998; Mill et al., 2003). Therefore, we
conclude that the budding phenotype in Gli2−/− UGS is a
result of partial disruption of Hh signaling.
Two features of the Gli2−/− grafts were notable. The first is
the deficiency in expression of the progenitor cell markers
Nestin and Bmi-1. Shh-Gli signaling has been implicated in
progenitor cell proliferation in several systems. Autocrine Shh-
Gli signaling is found in germinal cell populations in the
developing CNS and pathway activity is required for main-
tenance and expansion of progenitors with stem cell properties
(Palma and Ruiz i Altaba, 2004; Machold et al., 2003). Hh
signaling is required for progenitor cell proliferation during gut
development (Ramalho-Santos et al., 2000) and Hh signaling
controls the formation and expansion of epithelial progenitors in
the developing pancreas (Kawahira et al., 2005). Autocrine
pathway activation is also present in subsets of epithelial cells in
adult organs and this activity is believed to play a critical role in
maintenance of stem cells and in the regenerative response to
injury (Beachy et al., 2004). Hh pathway activity has been
observed, for example, in epithelial cells of the adult stomachand gall bladder (Berman et al., 2003) and focal pathway
activation is observed in the epithelium during the response to
injury in lung (Stewart et al., 2003; Watkins et al., 2003). And
interestingly, Karhadkar et al. (2004) showed that transfection
of prostate cancer cells with Gli1 increased expression of
Nestin. The diminished expression of Nestin and Bmi-1 in the
Gli2−/− grafts appears to suggest an important role for positive
Hh signaling in progenitor cell proliferation or maintenance.
The second notable feature of the Gli2−/− grafts was the
appearance of epithelial hyperplasia. The effect of Hh signaling
on epithelial proliferation during prostate development appears
convoluted. When cyclopamine inhibition of hedgehog signal-
ing is initiated in the pre-bud E14 mouse UGS, epithelial cell
proliferation is decreased and total number of prostatic buds is
apparently reduced (Lamm et al., 2002). However, when
initiated later in development, i.e., in the E16.5 mouse UGS
or the neonate rat ventral prostate (VP), cyclopamine treatment
produces opposite effects: epithelial cell proliferation is
increased, prostate growth is enhanced, and number of ducts
is either increased or not significantly affected (Wang et al.,
2003; Berman et al., 2004). Concurrent with ductal canalization,
epithelial cells differentiate into basal and luminal cells which
exhibit distinctive expression patterns of cytokeratins (CKs) and
p63 (Hayward et al., 1996). Exogenous Shh was found to
increase the proportion of epithelial cells that did not express
Krt1-14 and p63, indicative of increased luminal cell differ-
entiation; conversely, cyclopamine disruption of signaling
inhibited differentiation (Wang et al., 2003). Collectively,
these data may indicate a possible shift in the activities of Shh
signaling in prostate morphogenesis from promoting bud
formation and outgrowth via increased epithelial cell prolifera-
tion to inhibiting epithelial proliferation and promoting
differentiation. Our finding that Gli2 LOF is not accompanied
by an increase in Ki67+ (proliferating) cells suggests that the
observed epithelial hyperplasia is not a result of active
proliferation of the luminal compartment but rather the
consequence of impaired luminal cell differentiation, leading
to an accumulation of p63+ basal cells. Thus, these data are
consistent with a proposed role for Hh signaling in driving
epithelial differentiation postnatally.
In summary, this study demonstrated greater functional
redundancy of Hh signaling in the developing prostate than
previously suspected. Our studies show that functional redun-
dancy of Hh signaling exists both at the level of the Hh ligand and
in downstream transcriptional activation by Gli transcription
factors during prostate development. The compensatory action of
Ihh in the Shh−/− UGS maintains Hh signaling activity. Whether
this effectively rescues all Hh-dependent features of prostate
development remains uncertain. Similarly, other Gli transcription
factors compensate for the loss of Gli2 and act to maintain Hh-
induced transcriptional activation in the Gli2−/− UGS. As a
consequence, neither genetic inactivation of Shh nor Gli2 is
adequate to completely disrupt the Hh pathway in early prostate
development. A definitive assessment of the role of Hh signaling
in prostate development will require a more sophisticated
approach that can circumvent the functional resilience of a
highly redundant system.
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